Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Essex enriches and complements Emmes’ services
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
The observations are procedural in nature
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
Expands robotics to 20+ specialities
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Proposed combination enhances Pfizer’s position as a leading company in oncology
The company will be submitting the responses to US FDA observations within stipulated timeline
Subscribe To Our Newsletter & Stay Updated